Nightingale and BioBank Japan to realise personalised medicine and preventative health in Japan
Press release28 October 2021 at 9:00 (EEST) Nightingale Health Plc’s Japanese subsidiary Nightingale Health Japan KK (together ”Nightingale”) announces a long-term collaboration with BioBank Japan, one of the largest disease biobanks in the world with more than 200 000 participants nationwide, in a joint research effort that aims to identify distinctive aspects of disease risks in the Japanese population to realise personalised medicine and prevention in Japan. The parties started the collaboration in November 2020 with a pilot phase and are continuing the project with ongoing sample